Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Chemmedchem
|
April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>
Jérémie Mortier, Anders Friberg, Volker Badock, et al.
Journal of Medicinal Chemistry
|
May 22, 2013
Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9
Svetlana V Selivanova, Timo Stellfeld, Tobias K Heinrich, et al.
Molecular Cancer Therapeutics
|
August 18, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance
Maria Quanz, Eckhard Bender, Charlotte Kopitz, et al.
Nuclear Medicine and Biology
|
May 24, 2014
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability
Adrienne Müller, Stefanie D Krämer, Romana Meletta, et al.
ACS Combinatorial Science
|
August 13, 2016
Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral Fragments
Sina Haftchenary, Shawn D Nelson, Laura Furst, et al.
Leukemia
|
April 4, 2019
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
Sven Christian, Claudia Merz, Laura Evans, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Clara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Journal of Medicinal Chemistry
|
April 28, 2023
Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein-Protein Interaction Modulator with the Potential of Treating Hematological Malignancies
Fedor Romanov-Michailidis, Chien-Chi Hsiao, Lorenz M Urner, et al.
Journal of Medicinal Chemistry
|
February 28, 2018
Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design
Fredrik Rahm, Jenny Viklund, Lionel Trésaugues, et al.
Journal of Medicinal Chemistry
|
October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Lars Wortmann, Nico Bräuer, Simon J Holton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Chemmedchem
|
April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>
Jérémie Mortier, Anders Friberg, Volker Badock, et al.
Journal of Medicinal Chemistry
|
May 22, 2013
Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9
Svetlana V Selivanova, Timo Stellfeld, Tobias K Heinrich, et al.
Molecular Cancer Therapeutics
|
August 18, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance
Maria Quanz, Eckhard Bender, Charlotte Kopitz, et al.
Nuclear Medicine and Biology
|
May 24, 2014
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability
Adrienne Müller, Stefanie D Krämer, Romana Meletta, et al.
ACS Combinatorial Science
|
August 13, 2016
Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral Fragments
Sina Haftchenary, Shawn D Nelson, Laura Furst, et al.
Leukemia
|
April 4, 2019
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies
Sven Christian, Claudia Merz, Laura Evans, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Clara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Journal of Medicinal Chemistry
|
April 28, 2023
Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein-Protein Interaction Modulator with the Potential of Treating Hematological Malignancies
Fedor Romanov-Michailidis, Chien-Chi Hsiao, Lorenz M Urner, et al.
Journal of Medicinal Chemistry
|
February 28, 2018
Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design
Fredrik Rahm, Jenny Viklund, Lionel Trésaugues, et al.
Journal of Medicinal Chemistry
|
October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Lars Wortmann, Nico Bräuer, Simon J Holton, et al.
Page
of 3